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Background
• Trauma induced coagulopathy presents significant
challenges in caring for this patient population.

• Further complicating management of coagulopathy
in trauma patients are those with underlying
bleeding disorders.
Case Presentation
Patient is a 44 year-old male with a known history of
von Willebrand’s disease, reported ITP, was brought
to the emergency room as a level 1 trauma
activation after being found down in his home, 3
hours after being involved in a motorcycle crash. He
arrived in the trauma bay hypotensive and
tachycardic, with a GCS of 14, and a positive FAST
exam.

Clinical Course (continued)

Discussion

Patient received an additional 6 pRBC, 6 FFP, 3 6-pk
of platelets, and 2 cryoprecipitate, and blood pressure
normalized. Later that night, patient had a CT scan,
which showed active extravasation in the splenic bed.
He was taken to IR for angiogram, which showed the
splenic artery stump filling via collaterals. The splenic
artery was successfully coil embolized. The patient
was taken back to the operating room for reexploration. No active bleeding was noted. Multiple
hemostatic agents were placed in the splenic bed, a
Blake drain was placed, and the abdomen was
closed. The patient progressed well clinically. He
remained hemodynamically appropriate; his chest
tubes were removed, tolerating a regular diet, and he
was discharged home.

• Perioperative considerations are essential in
minimizing bleeding risk postoperatively
• Deficiencies and defects in von Willebrand's
factor leads to clinically relevant bleeding
disorders collectively known as von Willebrand’s
disease
• Immune thrombocytopenia purpura is often a
result antiplatelet autoantibodies resulting in a
low platelet count, purpura and episodic
hemorrhage.
• Bleeding can be mitigated with resuscitation that
includes vWF, especially in trauma with vWD.
• Close monitoring is recommended 7-14 days,
until bleeding risk abates.
• Splenectomy is the definitive treatment for ITP
refractory to medical therapy.
• Perioperative
considerations
and
risk
stratification are essential for preoperative
management of patients with vWD and ITP.

Clinical Course

Image
The patient was taken emergently to the OR
exploratory laparotomy and MTP was initiated.
Exploratory laparotomy was performed, with
evacuation of large volume hemoperitoneum. There
was active bleeding from the spleen,
and a
splenectomy was performed. Patient received a total
of 6 pRBC, 6 FFP, 2 6-pk platelets, 1 cryo, 1 DDAVP,
2 doses of vWF/factor VIII, intraoperatively. Blood
pressure responded well and patient was no longer
requiring pressors. Shortly after arriving to the ICU,
the open abdomen negative pressure therapy
dressing had increasing bloody output, and patient
became hypotensive despite reinitiating of blood
products. Bedside re-exploration was performed, with
evacuation of hematoma, and suture ligation of the
splenic artery. The abdomen was packed with lap
sponges and combat gauze, and open abdomen
negative pressure therapy was re-placed.
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Fig 1. Cross sectional imaging.
CTA revealing splenic arterial extravasation.
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